压力导丝在慢性完全闭塞病变介入治疗中的临床应用价值-CPSmd.PDF

2016 5 37 3 Adv Cardiovasc Dis ，May 2016 ，Vol. 37 ，No. 3 2·43 · 心血管病学进展 年 月第 卷第 期 tients undergoing percutaneous coronary intervention for acute myocardial infarc- results from the INFUSE-AMI trial ［J］. Circ Cardiovasc Interv，2013 ，6 (5 ): :1033-1035. tion ［J］. Am J Cardiol，2004 ，93 (8) 527-534. ［30］Ali A ，Cox D ，Dib N ，et al. Ｒheolytic thrombectomy with percutaneous coro- ［34］Niccoli G ，Ｒigattieri S ，de Vita MＲ ，et al. Open-label ，randomized ，placebo-con- nary intervention for infarct size reduction in acute myocardial infarction :30-day trolled evaluation of intracoronary adenosine or nitroprusside after thrombus aspi- results from a multicenter randomized study ［J］. J Am Coll Cardiol，2006 ，48 ration during primary percutaneous coronary intervention for the prevention of (2):244-252. microvascular obstruction in acute myocardial infarction :the ＲEOPEN-AMI ［31］Migliorini A ，Stabile A ，Ｒodriguez AE ，et al. Comparison of AngioJet rheolytic study (Intracoronary Nitroprusside Versus Adenosine in Acute Myocardial In- thrombectomy before direct infarct artery stenting with direct stenting alone in farction)［J］. JACC Cardiovasc Interv，2013 ，6 (6):580-589. patients with acute myocardial infarction. The JETSTENT trial ［J］. J Am Coll ［35］Windecker S ，Kolh P ，Alfonso F ，et al. 2014 ESC /EACTS Guidelines on myo- Cardiol ，2010 ，56 (16):1298-1306. cardial revascularization :The Task Force on Myocardial Ｒevascularization of the ［32］Stone GW ，Maehara A ，Witzenbichler B ，et al. Intracoronary abciximab and as- European Society of Cardiology (ESC)and the European Association for Cardio- piration thrombectomy in patie